Literature DB >> 19855403

The follicular versus marginal zone B lymphocyte cell fate decision.

Shiv Pillai1, Annaiah Cariappa.   

Abstract

Bone marrow-derived B cells make an important cell fate choice to develop into either follicular B cells or marginal zone B cells in the spleen, which depends on signalling through the B cell receptor, Notch2, the receptor for B cell-activating factor and the canonical nuclear factor-kappaB pathway, as well as signals involved in the migration and anatomical retention of marginal zone B cells. Recent information discussed in this Review reconciles some of the controversies regarding the role of the B cell receptor in this cell fate decision and a clearer picture has also emerged regarding the anatomical location of ligands for Notch2 in the spleen. This cell fate decision could provide mechanistic insights that are relevant to other commitment events in lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855403     DOI: 10.1038/nri2656

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  104 in total

1.  Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.

Authors:  F Martin; J F Kearney
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells.

Authors:  Kenji Tanigaki; Hua Han; Norio Yamamoto; Kei Tashiro; Masaya Ikegawa; Kazuki Kuroda; Akira Suzuki; Toru Nakano; Tasuku Honjo
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

3.  CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.

Authors:  Dennis C Otero; Amy N Anzelon; Robert C Rickert
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

4.  Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.

Authors:  Zhong Huang; Lei Nie; Min Xu; Xiao-Hong Sun
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 5.  Microcirculatory pathways and blood flow in spleen: new insights from washout kinetics, corrosion casts, and quantitative intravital videomicroscopy.

Authors:  A C Groom; E E Schmidt; I C MacDonald
Journal:  Scanning Microsc       Date:  1991-03

6.  Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response.

Authors:  Anatoly Rubtsov; Pamela Strauch; Alyssa Digiacomo; Jiancheng Hu; Roberta Pelanda; Raul M Torres
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

7.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

8.  Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.

Authors:  Astrid A Ruefli-Brasse; Dorothy M French; Vishva M Dixit
Journal:  Science       Date:  2003-10-23       Impact factor: 47.728

9.  The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development.

Authors:  Lizi Wu; Ivan Maillard; Makoto Nakamura; Warren S Pear; James D Griffin
Journal:  Blood       Date:  2007-08-15       Impact factor: 22.113

10.  B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase.

Authors:  Annaiah Cariappa; Hiromu Takematsu; Haoyuan Liu; Sandra Diaz; Khaleda Haider; Cristian Boboila; Geetika Kalloo; Michelle Connole; Hai Ning Shi; Nissi Varki; Ajit Varki; Shiv Pillai
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

View more
  229 in total

1.  N-Glycan Branching Is Required for Development of Mature B Cells.

Authors:  Christie-Lynn Mortales; Sung-Uk Lee; Michael Demetriou
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  Recruitment of a distinct but related set of VH sequences into the murine CD21hi/CD23- marginal zone B cell repertoire to that seen in the class-switched antibody response.

Authors:  Henry N White; Qing-Hai Meng
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

3.  The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12.

Authors:  Hongsheng Wang; Natalie Beaty; Sophia Chen; Chen-Feng Qi; Marek Masiuk; Dong-Mi Shin; Herbert C Morse
Journal:  Blood       Date:  2011-11-22       Impact factor: 22.113

Review 4.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

5.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

6.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

7.  SHEP1 partners with CasL to promote marginal zone B-cell maturation.

Authors:  Cecille D Browne; Melanie M Hoefer; Suresh K Chintalapati; Matthew H Cato; Yann Wallez; Derek V Ostertag; Elena B Pasquale; Robert C Rickert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

Review 8.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

9.  Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Authors:  Xizhang Sun; Alice Wiedeman; Nalini Agrawal; Thomas H Teal; Lena Tanaka; Kelly L Hudkins; Charles E Alpers; Silvia Bolland; Matthew B Buechler; Jessica A Hamerman; Jeffrey A Ledbetter; Denny Liggitt; Keith B Elkon
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

10.  Ezrin tunes the magnitude of humoral immunity.

Authors:  Debasis Pore; Neetha Parameswaran; Ken Matsui; Matthew B Stone; Ichiko Saotome; Andrea I McClatchey; Sarah L Veatch; Neetu Gupta
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.